Roger D Kitterman

Bio

Roger Kitterman joined Mi3 Venture Partners in 2003. Roger is an experienced venture capital investor and has guided multiple venture-backed companies through the earliest stages of development. He represents Mi3 on the Board of FlowMedica. Roger has over ten years of venture capital experience investing in healthcare companies. He has also been the startup CEO for three venture-backed companies. Prior to joining Mi3, he was a managing director at Lee Munder Venture Partners, the venture capital arm of Lee Munder Capital Group. He joined Lee Munder from Boston University's Community Technology Fund, where he made venture capital investments in the life sciences and developed spinouts from the university. Roger began his venture capital career in Eastern Europe with the Bulgarian-American Enterprise Fund, a $55 million venture capital fund. Roger's track record includes investments in AtheroGenics (NASDAQ: AGIX), Exact Sciences (NASDAQ: EXAS), NitroMed (NASDAQ: NTMD), and Sequenom (NASDAQ: SQNM). Roger received his M.B.A. (Finance and Business Development) from the Columbia School of Business and his B.A. from Harvard College.